Difference between revisions of "Team:TUDelft/Home"

 
(17 intermediate revisions by 2 users not shown)
Line 4: Line 4:
 
         <div class="col s12 m10">
 
         <div class="col s12 m10">
 
             <!-- HERE YOU CAN TYPE YOUR STUFF -->
 
             <!-- HERE YOU CAN TYPE YOUR STUFF -->
−
             <script src="https://2017.igem.org/Team:TUDelft/js/start-slider?action=raw&ctype=text/javascript"></script>
+
             <script src="https://2017.igem.org/Team:TUDelft/js/start-slider-after?action=raw&ctype=text/javascript"></script>
−
             <div id="animated-logo" class=""><img src="https://static.igem.org/mediawiki/2017/c/c1/Logo_met_meer_witte_schaduw.png" style="height: 40vw" /></div>
+
             <!-- <div id="animated-logo" class=""><img src="https://static.igem.org/mediawiki/2017/c/c1/Logo_met_meer_witte_schaduw.png" style="height: https://static.igem.org/mediawiki/2017/e/ea/T--TUDelft--logo-hor.png40vw" /></div> -->
  
 
             <div class="slider">
 
             <div class="slider">
 
                 <ul class="slides">
 
                 <ul class="slides">
−
                     <li id="sliding-logo">
+
                    <li><img src="https://static.igem.org/mediawiki/2017/d/d9/T--TUDelft--2017_Foto_1.1.min.png" /></li>
−
                        <img src="https://static.igem.org/mediawiki/2017/e/ea/T--TUDelft--logo-hor.png" style="margin-left: 5%; margin-right: 5%; width: 90%;" />
+
                     <li id="sliding-logo"><img src="https://static.igem.org/mediawiki/2017/a/a0/T--TUDelft--2017_Foto_2.1.min.png" /></li>
−
                    </li>
+
                    <li><img src="https://static.igem.org/mediawiki/2017/e/e0/T--TUDelft--2017_Foto_3.min.jpg" /></li>
−
 
+
                    <li><img src="https://static.igem.org/mediawiki/2017/9/95/T--TUDelft--2017_Foto_4.min.jpg" /></li>
−
                     <li>
+
                    <li><img src="https://static.igem.org/mediawiki/2017/4/4e/T--TUDelft--2017_Foto_5.min.jpg" /></li>
−
                        <img src="https://static.igem.org/mediawiki/2017/7/74/T--TUDelft--Grouppic.jpeg" />
+
                    <li><img src="https://static.igem.org/mediawiki/2017/1/12/T--TUDelft--2017_Foto_6.min.jpg" /></li>
−
                    </li>
+
                    <li><img src="https://static.igem.org/mediawiki/2017/4/42/T--TUDelft--2017_Foto_7.min.jpg" /></li>
−
                     <li>
+
                    <li id="sliding-logo"><img src="https://static.igem.org/mediawiki/2017/e/ea/T--TUDelft--logo-hor.png" style="margin-left: 5%; margin-right: 5%; width: 90%;" /></li>
−
                        <video class="responsive-video center-margin" style="width: 100%" controls autoplay muted>
+
                     <li><img src="https://static.igem.org/mediawiki/2017/7/74/T--TUDelft--Grouppic.jpeg" /></li>
 +
                     <li><video class="responsive-video center-margin" style="width: 100%" controls autoplay muted>
 
                             <source src="https://static.igem.org/mediawiki/2017/5/56/T--TUDelft--2017_meetup_wikiproof.min.mp4" type="video/mp4">
 
                             <source src="https://static.igem.org/mediawiki/2017/5/56/T--TUDelft--2017_meetup_wikiproof.min.mp4" type="video/mp4">
−
                         </video>
+
                         </video></li>
−
                    </li>
+
                   
 
                 </ul>
 
                 </ul>
 
             </div>
 
             </div>
Line 26: Line 27:
  
  
 +
            <div  class="section card ">
 +
                <div class='card-content'>
 
             <div class="row">
 
             <div class="row">
  
Line 33: Line 36:
  
 
                 <div class="col m2 s12">
 
                 <div class="col m2 s12">
−
                     <a href="https://2017.igem.org/Team:TUDelft/Sponsors"><img src=https://static.igem.org/mediawiki/2017/d/da/T--TUDelft--2017_SPONSORYES.png alt='Sponsor' class="responsive-img"></a>
+
                     <a href="https://2017.igem.org/Team:TUDelft/HP/Gold_Integrated"><img src=https://static.igem.org/mediawiki/2017/0/05/T--TUDelft--2017_IHPYES.png alt='IHP' class="responsive-img"></a>
 +
                   
 
                 </div>
 
                 </div>
  
Line 39: Line 43:
 
                     <a href="https://2017.igem.org/Team:TUDelft/Modeling"><img src=https://static.igem.org/mediawiki/2017/7/74/T--TUDelft--2017_MODELYES.png alt='Modeling' class="responsive-img"></a>
 
                     <a href="https://2017.igem.org/Team:TUDelft/Modeling"><img src=https://static.igem.org/mediawiki/2017/7/74/T--TUDelft--2017_MODELYES.png alt='Modeling' class="responsive-img"></a>
 
                 </div>
 
                 </div>
 +
             
 
                 <div class="col m2 s12">
 
                 <div class="col m2 s12">
 +
                    <a href="https://2017.igem.org/Team:TUDelft/Parts"><img src=https://static.igem.org/mediawiki/2017/4/42/T--TUDelft--2017_PARTSYES.png alt='Parts' class="responsive-img"></a>
 +
                </div>
 +
                <div class="col m2 s12">
 
                     <a href="https://2017.igem.org/Team:TUDelft/Software"><img src=https://static.igem.org/mediawiki/2017/a/a0/T--TUDelft--2017_SOFTWAREYES.png alt='Software' class="responsive-img"></a>
 
                     <a href="https://2017.igem.org/Team:TUDelft/Software"><img src=https://static.igem.org/mediawiki/2017/a/a0/T--TUDelft--2017_SOFTWAREYES.png alt='Software' class="responsive-img"></a>
 
                 </div>
 
                 </div>
 
                 <div class="col m2 s12">
 
                 <div class="col m2 s12">
−
                     <a href="https://2017.igem.org/Team:TUDelft/Parts"><img src=https://static.igem.org/mediawiki/2017/4/42/T--TUDelft--2017_PARTSYES.png alt='Parts' class="responsive-img"></a>
+
                     <a href="https://2017.igem.org/Team:TUDelft/Sponsors"><img src=https://static.igem.org/mediawiki/2017/d/da/T--TUDelft--2017_SPONSORYES.png alt='Sponsor' class="responsive-img"></a>
−
                </div>
+
−
                <div class="col m2 s12">
+
−
                    <a href="https://2017.igem.org/Team:TUDelft/HP/Gold_Integrated"><img src=https://static.igem.org/mediawiki/2017/0/05/T--TUDelft--2017_IHPYES.png alt='IHP' class="responsive-img"></a>
+
 
                 </div>
 
                 </div>
 
             </div>
 
             </div>
  
−
 
+
</div>
−
 
+
        </div>
  
 
             <!--------------------------------------------->
 
             <!--------------------------------------------->
−
             <p>Indiscriminate usage of antibiotics allows pathogenic bacteria to develop mechanisms that render these antibiotics ineffective.</p>
+
             <p>Indiscriminate usage of antibiotics allows pathogenic bacteria to develop mechanisms that render these antibiotics ineffective.
  
 
            
 
            
 
             <!-- Image antibiotic resistance development-->
 
             <!-- Image antibiotic resistance development-->
−
             <p>Especially in the animal sector, antibiotics are still overused. Bacteria that develop antibiotic resistance there, can spread via food or direct contact, posing a threat to human health. It is estimated that by 2050, 10 million people will die annually due to antibiotic resistant bacteria (<a href='#References'>O’Neill, 2014).</a></p>
+
             Especially in the animal sector, antibiotics are still overused. Bacteria that develop antibiotic resistance there, can spread via food or direct contact, posing a threat to human health. It is estimated that by 2050, 10 million people will die annually due to antibiotic resistant bacteria (<a href='#References'>O’Neill, 2014).</a></p>
 
             <div class="row">
 
             <div class="row">
 
                 <div class="col s6">
 
                 <div class="col s6">
Line 83: Line 88:
 
             <center><i>Schematic of our project</i></center>
 
             <center><i>Schematic of our project</i></center>
 
             <p>Our project consists of three parts: a recently characterized variant of the CRISPR/Cas system (Cas13a) for fast and accurate detection; tardigrade proteins that increase the shelf-life of our device; and the coacervation method for visible read-out. Moreover, we aim to use cells as mini-factories through the use of vesicles, truly transforming bacteria in genetically engineered machines.</p>
 
             <p>Our project consists of three parts: a recently characterized variant of the CRISPR/Cas system (Cas13a) for fast and accurate detection; tardigrade proteins that increase the shelf-life of our device; and the coacervation method for visible read-out. Moreover, we aim to use cells as mini-factories through the use of vesicles, truly transforming bacteria in genetically engineered machines.</p>
−
             <h5><b><i>Our project tackles one of the biggest challenges our society faces in the coming years - we offer a durable device that contributes to the reduction of antibiotic resistance. Furthermore, our device is easily adaptable to detect any kind of DNA/RNA sequence, opening doors for the rapid diagnosis of many diseases.</i></b></h5>
+
             <blockquote>Our project tackles one of the biggest challenges our society faces in the coming years - we offer a durable device that contributes to the reduction of antibiotic resistance. Furthermore, our device is easily adaptable to detect any kind of DNA/RNA sequence, opening doors for the rapid diagnosis of many diseases.</blockquote>
  
−
             <div id="references" class="section card blue lighten-5">
+
             <div id="references" class="section card">
 
                 <div class='card-content'>
 
                 <div class='card-content'>
 
                     <span class='card-title'>References:</span>
 
                     <span class='card-title'>References:</span>

Latest revision as of 21:16, 14 December 2017

Project
IHP
Modeling
Parts
Software
Sponsor

Indiscriminate usage of antibiotics allows pathogenic bacteria to develop mechanisms that render these antibiotics ineffective. Especially in the animal sector, antibiotics are still overused. Bacteria that develop antibiotic resistance there, can spread via food or direct contact, posing a threat to human health. It is estimated that by 2050, 10 million people will die annually due to antibiotic resistant bacteria (O’Neill, 2014).

Schematic of the development of antibiotic resistance and how it can spread to humans

The goal of our project is to develop a tool that will enable farmers to test on-site if a cow suffering from a bacterial infection is infected with antibiotic resistant bacteria. Based on the output, they can adapt their antibiotics usage, resulting in a more targeted treatment.

Schematic of our project

Our project consists of three parts: a recently characterized variant of the CRISPR/Cas system (Cas13a) for fast and accurate detection; tardigrade proteins that increase the shelf-life of our device; and the coacervation method for visible read-out. Moreover, we aim to use cells as mini-factories through the use of vesicles, truly transforming bacteria in genetically engineered machines.

Our project tackles one of the biggest challenges our society faces in the coming years - we offer a durable device that contributes to the reduction of antibiotic resistance. Furthermore, our device is easily adaptable to detect any kind of DNA/RNA sequence, opening doors for the rapid diagnosis of many diseases.